Cite
Kurzawa-Akanbi M, Tammireddy S, Fabrik I, et al. Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of alpha-synuclein in Lewy body disorders. Acta Neuropathol. 2021;142(6):961-984doi: 10.1007/s00401-021-02367-3.
Kurzawa-Akanbi, M., Tammireddy, S., Fabrik, I., Gliaudelytė, L., Doherty, M. K., Heap, R., Matečko-Burmann, I., Burmann, B. M., Trost, M., Lucocq, J. M., Gherman, A. V., Fairfoul, G., Singh, P., Burté, F., Green, A., McKeith, I. G., Härtlova, A., Whitfield, P. D., & Morris, C. M. (2021). Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of alpha-synuclein in Lewy body disorders. Acta neuropathologica, 142(6), 961-984. https://doi.org/10.1007/s00401-021-02367-3
Kurzawa-Akanbi, Marzena, et al. "Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of alpha-synuclein in Lewy body disorders." Acta neuropathologica vol. 142,6 (2021): 961-984. doi: https://doi.org/10.1007/s00401-021-02367-3
Kurzawa-Akanbi M, Tammireddy S, Fabrik I, Gliaudelytė L, Doherty MK, Heap R, Matečko-Burmann I, Burmann BM, Trost M, Lucocq JM, Gherman AV, Fairfoul G, Singh P, Burté F, Green A, McKeith IG, Härtlova A, Whitfield PD, Morris CM. Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of alpha-synuclein in Lewy body disorders. Acta Neuropathol. 2021 Dec;142(6):961-984. doi: 10.1007/s00401-021-02367-3. Epub 2021 Sep 13. PMID: 34514546; PMCID: PMC8568874.
Copy
Download .nbib